Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Advocates suggest it can help repair tissues, from the digestive system to muscles, tendons, and ligaments
Laboratories comparing delivery routes for this blend can also review the BPC-157 and TB-500 intranasal spray, supplied pre-mixed with no reconstitution step
Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture
Severe hypoglycemia caused 4 hospital-grade seizures or loss-of-consciousness events out of 71 patients in the Increlex program it is not a theoretical risk
The mechanism through which it promotes fat loss, primarily beta-3 adrenergic receptor activation, is completely separate from IGF-1 signaling
